We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
-3.68%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$982M
AUM Growth
+$92.9M
Cap. Flow
+$134M
Cap. Flow %
13.65%
Top 10 Hldgs %
4.69%
Holding
1,940
New
653
Increased
414
Reduced
285
Closed
576

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$4.61M
2
DPZ icon
Domino's
DPZ
+$3.96M
3
BRKR icon
Bruker
BRKR
+$3.65M
4
TJX icon
TJX Companies
TJX
+$3.62M
5
SBUX icon
Starbucks
SBUX
+$3.58M

Sector Composition

Rank Sector Weight
1 Healthcare 17.3%
2 Industrials 16.2%
3 Technology 12.7%
4 Financials 11.7%
5 Consumer Discretionary 9.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EXTN
326
DELISTED
Exterran Corporation
EXTN
$964K 0.1%
217,101
+110,172
+103% +$467K
TTD icon
327
Trade Desk
TTD
$6.49B
$962K 0.1%
13,681
+1,371
+11% +$106K
HAPN
328
Happen Inc
HAPN
$2.24B
$959K 0.1%
33,959
-42,913
-56% -$1.06M
KN icon
329
Knowles
KN
$3.34B
$956K 0.1%
51,022
+15,430
+43% +$302K
QUAL icon
330
iShares MSCI USA Quality Factor ETF
QUAL
$47.9B
$953K 0.1%
7,232
-1,961
-21% -$270K
PSNL icon
331
Personalis
PSNL
$1.51B
$950K 0.1%
49,364
+40,848
+480% +$854K
PEB icon
332
Pebblebrook Hotel Trust
PEB
$2.05B
$947K 0.1%
42,273
-18,849
-31% -$417K
ZGNX
333
DELISTED
Zogenix, Inc.
ZGNX
$946K 0.1%
62,297
-25,019
-29% -$391K
HCKT icon
334
Hackett Group
HCKT
$287M
$945K 0.1%
+48,164
New +$902K
PM icon
335
Philip Morris
PM
$295B
$945K 0.1%
9,969
+1,901
+24% +$191K
BIOR
336
DELISTED
Biora Therapeutics, Inc. Common Stock
BIOR
$935K 0.1%
+2,460
New +$1.05M
ATRS
337
DELISTED
Antares Pharma, Inc.
ATRS
$934K 0.1%
256,622
+16,319
+7% +$66K
GOCO
338
DELISTED
GoHealth
GOCO
$928K 0.09%
+12,305
New +$1.3M
DKS icon
339
Dick's Sporting Goods
DKS
$18.7B
$926K 0.09%
7,734
-16,898
-69% -$1.96M
HURN icon
340
Huron Consulting
HURN
$2.42B
$923K 0.09%
17,747
-576
-3% -$28K
OEF icon
341
iShares S&P 100 ETF
OEF
$20.6B
$923K 0.09%
4,673
+1,039
+29% +$211K
TRAW icon
342
Traws Pharma
TRAW
$8.1M
$922K 0.09%
+9,626
New +$1.24M
URI icon
343
United Rentals
URI
$72.4B
$920K 0.09%
2,623
+1,903
+264% +$639K
VERU icon
344
Veru
VERU
$37.4M
$920K 0.09%
+10,785
New +$856K
GAP
345
The Gap Inc
GAP
$7.37B
$920K 0.09%
40,523
+32,223
+388% +$890K
MTH icon
346
Meritage Homes
MTH
$4.86B
$918K 0.09%
+18,918
New +$974K
RBC icon
347
RBC Bearings
RBC
$18B
$917K 0.09%
4,320
-4,259
-50% -$925K
SIOX
348
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$916K 0.09%
422,148
+58,261
+16% +$127K
DHT icon
349
DHT Holdings
DHT
$3.02B
$915K 0.09%
140,058
+126,538
+936% +$733K
HOG icon
350
Harley-Davidson
HOG
$2.71B
$915K 0.09%
+24,982
New +$1.01M

Similar funds

GSA Capital Partners's Q3 2021 Portfolio in Review

As of Q3 2021, GSA Capital Partners held 1,940 positions worth $982M, up 10% from $889M the previous quarter. Its ten largest holdings account for 4.7% of the portfolio.

GSA Capital Partners deployed $134M of net new capital in Q3 2021, opening 653 new positions and adding to 414 existing holdings. Its largest new stake was Openlane: 280,405 shares worth $4.6M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 15% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was Amazon, an estimated $4.61M trimmed.

  • GSA Capital Partners's largest Q3 2021 buy was Openlane: 280,405 shares worth $4.6M.
  • GSA Capital Partners added most to BridgeBio Pharma in Q3 2021, an estimated $4.54M increase.
  • GSA Capital Partners's biggest Q3 2021 reduction was Amazon, cutting an estimated $4.61M.
  • GSA Capital Partners fully exited TJX Companies in Q3 2021, selling an estimated $3.62M.
  • GSA Capital Partners's ten largest holdings make up 4.7% of its $982M portfolio in Q3 2021.
  • GSA Capital Partners opened 653 new positions and closed 576 in Q3 2021.
  • GSA Capital Partners's portfolio value rose 10% quarter-over-quarter to $982M.

Based on GSA Capital Partners's 13F filing for Q3 2021, filed 12 Nov 2021.